Alyssa Schledwitz is an Internal Medicine resident physician at the University of Maryland Medical Center. She graduated from the University of Maryland School of Medicine, where her research focused on the divergent roles of the M1 and M3 muscarinic receptors in the development of colon cancer. As a trainee in UMMC's physician-scientist training program in gastroenterology and hepatology, she continues to study the colon cancer tumor microenvironment with the aim of identifying potential biomarkers and treatment targets for advanced disease. Her other professional interests include inflammatory bowel disease, colitis-associated colon cancer, and medical education.